Allergy/Imm

Your Article Summary

See Latest Articles

Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience
Expert Review of Vaccines, 10/08/09

Zhu J et al. – The carbohydrate–based anticancer vaccine program has evolved through a number of stages: monomeric vaccines, monomeric clustered vaccines, unimolecular multi–antigenic vaccines and dual–acting vaccines. This account will focus on the recently developed unimolecular multi–antigenic constructs and potential dual–acting constructs, which contain clusters of both carbohydrate and peptide epitopes.

Today in Hematology/Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia
Transplantation Proceedings, 11/23/09

Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer–Specific Immune Responses and Their Correlation to Prognosis
Cancer Research, 11/03/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09

See All of Hematology/Oncology

Today in Vaccine/Immunotherapy...keeping you current

Receive free subspecialty "5-minute updates" via email

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09

Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09

See All of Vaccine/Immunotherapy